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O

Background: Opioid abuse has been an increasing problem since the 1990s. With over 47,000
opioid related deaths recorded in 2017 alone, concerns have been raised regarding the dangers of
introducing opioids perioperatively to patients undergoing major surgeries.
Objectives: The present study proposes to examine the frequency, amount, and trends in postoperative opioid consumption in patients undergoing orthopedic surgical procedures.
Study Design: This was a randomized, retrospective questionnaire-based study.
Setting: Patients who underwent any type of orthopedic surgery at the University of Pennsylvania
Presbyterian Hospital from 1/1/2018 to 3/12/2019 were randomly selected and called during the
summer of 2019.
Methods: In this retrospective questionnaire-based study, 828 patients were called by telephone in
the summer of 2019. These patients were asked a variety of questions involving opioid consumption
behavior post-surgery. The study ended after receiving responses from 200 patients.
Results: Nineteen (9.5%) patients reported positively for experiencing euphoria while taking opioids
post-surgery. Of the 200 patients contacted, 6 patients (3%) reported switching to marijuana instead
of opioids. Thirty-eight (19%) patients preferred to take no opioids at all post-surgery, and one
patient was found to have given their prescription to a family member or friend. Twenty-one patients
(10.5%) were found to have been taking opioids for non-severe pain. Blacks and whites were the
most common racial demographics, making up 84 and 109 of the totals, respectively. The odds ratios
for all of the predictors showed that the relative risk for opioid misuse was higher for black patients
than white patients (OR = 3.034). There was no relationship between the intra- and post-operative
opioid administration and long-term opioid misuse.
Limitations: Patients are self-selected and had the option to opt out of the study when contacted.
Some patients may not have been available to answer the phone when our study was being conducted.
This study was only conducted for orthopedic patients and for patients who received surgery at the
University of Pennsylvania Presbyterian Hospital, thus affecting the demographics for our research.
Conclusions: Prescription opioid misuse is more common among the black population. The total
opioid consumption is frequently lower than the quantity prescribed. Patients frequently use opioids
even though they feel that pain is insufficient to deserve such an intervention. Euphoria is experienced
by a significant number of patients taking prescription opioids Often patients do not take any opioids,
although they had prescriptions.
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pioid abuse has been rapidly increasing
since the early 1990s (1). Prior to the 1990s,
opioid painkillers were primarily prescribed
to cancer patients (1). However, in 1991 pharmaceutical

companies began to downplay the long-term negative
consequences of opioids. This led to a sharp increase
in opioid prescriptions for noncancer related pain (1).
This first wave of the opioid epidemic was followed by a
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second wave in 2010, where heroin became a cheaper
and easier to obtain alternative for opioids (2). In 2013,
use of synthetic opioids began to increase as well, one
of which being the drug fentanyl, a very common
anesthesia medication given to a majority of patients
undergoing surgery (2). Deaths from opioid abuse
have become increasingly common among Americans.
In 2017, over 47,000 deaths were recorded due to
prescription and nonprescription opioid overdose, and
deaths are projected to reach nearly 82,000 by 2025 (3).
The opioid epidemic has also created a large economic
burden for the country, as increased healthcare and
substance abuse treatment has cost the United States
upwards of $78 billion a year (4).
With the opioid epidemic becoming a major public
health concern, studies have been conducted to determine the likely contributing factors. Concerns have
been raised about the dangers of introducing opioids
perioperatively to an opioid naive patient. One study
in 2016 found that male and elderly patients (over 50
years of age) with histories of substance abuse had
a greater risk of becoming opioid dependent postsurgery where opioids were introduced (5). Another
study concluded that a very small proportion of women
become opioid dependent following cesarean delivery
(6). Studies have also been conducted to determine
alternatives to opioid administration in an attempt to
reduce the amount of prescription painkillers given to
patients. A study in 2016 concluded that the administration of preoperative gabapentin reduced the total
opioid consumption 24 hours following surgery (7).
However, many of these studies fall short in predicting the patient factors that are likely to contribute
to opioid abuse. Furthermore, much of the literature
currently published relies on the amount of prescriptions filled by the patient as the opioid abuse indicator,
giving no evidence of whether the patient was actually
taking the medication and to what degree. The current study aims at directly determining the extent to
which patients consumed their postoperative opioid
prescriptions. As evidence suggests, even one tablet
of a particular opioid may lead to continued use of
opioids. In this study, we planned to examine whether
the perioperative introduction of opioids has any effect
on the patients’ immediate, intermediate, or long-term
postoperative seeking of opioids.

Methods
After obtaining the Institutional Review Board’s
approval, patient and procedural data from 1/1/2018
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to 3/12/2019 of all patients undergoing surgical procedures was obtained from the billing office. Patients
who underwent any type of orthopedic surgery at
the University of Pennsylvania Presbyterian Hospital
were randomly selected and called over the phone for
participation in our questionnaire-based study. Any
children under the age of 18 were excluded from the
sample. A total of 828 patients were called during the
hours of 9:00 AM to 5:00 PM and the study was stopped
after obtaining a total of 200 responses. The types of
procedures for each patient were categorized into one
of 19 major classifications.
Patients who answered the phone were questioned
for approximately 10 to 15 minutes. Verbal consent
was obtained from each of the patients participating
in the study prior to any questions being asked. The
questionnaire form was filled in real time. Preliminary
demographics, intraoperative opioid administration,
and postoperative opioid prescriptions were extracted
from the electronic medical records. The questions
included opioid consumption patterns during the
first week post-surgery and up to 6 months following
surgery. Patients were also asked about any euphoria they experienced under the influence of opioids,
whether they took opioids for nonsevere or no pain,
and whether the patient gave their opioid supplies to
any friends or family members. Furthermore, any other
pain management methods employed by the patient,
such as marijuana consumption, were noted and recorded. This study relied on the patient to remember
opioid consumption behavior during the time period
up to 6 months following surgery.
All data regarding opioid prescriptions and the
patient’s opioid consumption pattern (pill count)
were converted to the respective Morphine Milligram
Equivalent (MME) for comparison purposes. Conversion
factors for intravenous and prescription opioids were
taken from the center for Medicare and Medicaid services website. For patient prescriptions, the maximum
amount prescribed was used when calculating average
MME/day.
All data analysis was completed using IBM SPSS
Statistics (Version 25.0. Armonk, NY) for Macintosh.
Means and standard deviations were calculated
for prescribed opioid MME/day as well as consumed
MME/day per procedure (Fig. 1). Any procedures with
less than 4 patients were excluded from the summary
boxplot. All data were analyzed using binary logistic
regressions with a P value of 0.05 being considered as
significant in these comparisons. Statistical analysis was
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done for different cohorts of demographics as well as
perioperative indicators to determine whether opioid
misuse was occurring (Table 1).

Results
Of the 828 patients called for this study, a total
of 200 responses were recorded. These 200 responses
were then grouped into one of 19 procedural categories. Table 2 summarizes all of the demographics for
the 200 patients screened. All patients were grouped
by gender, ethnicity, age range, and body mass index

(BMI) range. Each of the patients were grouped into 4
different racial categories. Blacks and whites were the
most common racial demographics, making up 42%
and 54.5% of the totals respectively. Each of the patients contacted were also asked of their education levels. Patient education levels were grouped into one of
8 different categories and reported in Table 2 as well.
Averages and standard deviations for patient
prescriptions were also calculated for each of the procedural categories. These were then compared against
the averages and standard deviations for the patient

Fig. 1. Mean and standard deviations for prescription and consumption opioid MME/day for each procedure.
Table 1. Summary statistics.

Step 1a

95% C.I. for Odds Ratio
B

S.E.

Wald

df

Sig.

Odds Ratio

Lower

Upper

Gender

.649

.549

1.400

1

.237

1.914

.653

5.608

Age at Time of Surgery

.000

.022

.000

1

.989

1.000

.957

1.044

Race

1.110

.534

4.318

1

.038

3.034

1.065

8.640

Euphoric

.592

.786

.566

1

.451

1.807

.387

8.438

Intraoperative Opioid MME

.005

.018

.086

1

.770

1.005

.971

1.041

Prescription MME Day

.013

.009

1.900

1

.168

1.013

.995

1.032

-3.987

1.433

7.736

1

.005

.019

Constant
a

Variable(s) entered on Step 1: Gender, AgeatTimeofSurgery, Race, Euphoric, IntraopOpioidMME, PrescriptionMMEDay
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Table 2. Demographics of study.

Count
Gender

Ethnicity

Age Range

BMI Range

Highest Education
Level

Male

103

Female

97

White

109

Black

84

Asian

3

Hispanic or Latino

4

< 20

1

21 – 30

17

31 – 40

40

41 – 50

36

51 – 60

58

61 – 70

48

< 18.5

1

18.5 – 24.9

38

25.0 – 29.9

58

30.0

103

No formal education credential

8

High school diploma or equivalent

51

Some college, no degree

36

Postsecondary nondegree award

1

Associate’s degree

13

Bachelor’s degree

50

Master’s degree

20

Doctoral or professional degree

21

Type of Surgery
Amputation

5

Arthroplasty

61

Arthroplasty

50

Bilateral Spine Surgery

7

Bone Graft

3

Craniectomy

1

Dislocation

5

Excision

4

Fasciectomy

1

Fracture

13

Implant

9

Incision

9

Joint Aspiration

1

Laminotomy

4

Neuroplasty

9

Ruptured Tendon

5

Skin Graft

3

Sympathectomy

1

Tenotomy

2
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consumption pattern per day (MME/day) for each
procedure. Fig. 1 summarizes these results in a multi
boxplot format, however those surgeries with less than
4 patients were excluded from the diagram. As seen
from graph, the average patient consumption pattern
for all of the procedural categories shown was as much
or less than the prescribed MME/day.
We also screened our patients to determine
whether opioids were being consumed for pain that
was not reported as severe. Twenty-one patients out
of the 200 total (10.5%) were found to have been
taking opioids for nonsevere pain. For analytical purposes, we characterized any behavior involving the
consumption of opioids for non-severe or no pain as
opioid misuse.
Statistical analysis was used to determine which
predictors may affect the patient’s likeliness to misuse
opioids. A binary logistic regression was done for different predictors that may influence opioid misuse. Each
of the predictors that were included in the model are
seen in Table 1. Only patients who identified as black
or white were used in the model, due to low responses
from other ethnicities. The intraoperative opioid MME
administered during surgery as well as the prescription
MME/day for each of the patients were used as factors
to predict opioid misuse as well. Lastly, patients were
screened to determine whether they reported any feelings of euphoria while consuming the prescribed opioids, of which 19 patients reported positively (9.5%).
This was also used as a predictor in our model.
Although the model itself was not considered
significant (P = 0.140), it is worth noting that the race
predictor did report a significant finding (P = 0.038).
The odds ratios for all of the predictors are also reported in Table 1. As shown, the relative risk for opioid misuse was higher for black patients than white
patients (OR = 3.034, 95% Confidence Interval, 1.065
to 8.640).
Other forms of pain management such as marijuana were found to be effective for patients postsurgery, with 6 patients out of the 200 reporting to
have switched to marijuana instead of opioids (3%).
Although it is uncertain in what form these patients
used marijuana (whether medicinally or recreationally),
all patients who reported to have been self-prescribing
marijuana instead of opioids experienced significant
pain relief (self-reported by patients). Furthermore, 38
patients preferred to take no opioids at all post-surgery
(19%), and only one patient was found to have given
their prescription to a family member or friend.
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Discussion
As defined by the Federation of State Medical
Boards, opioid misuse “encompasses all uses of a prescription medication other than those that are directed
by a clinician.” This may include taking a dose when it
is not necessary, taking a larger dose than instructed, or
taking the dose in a different manner than prescribed,
such as through injection or snorting (8). This is distinct
from Opioid Use Disorder (OUD), which is also referred
to as opioid addiction. OUD or opioid addiction is
characterized by a powerful, compulsive urge to use
opioids when not medically required, which may result
in significant impairment or distress (9,10). Given these
definitions, for the purposes of our study, any patient
reported to have consumed opioids for non-severe pain
was characterized as misusing opioids.
Our study suggests that prescription opioid misuse is more common among the black population.
Furthermore, comparison between prescription opioid
amounts and patient consumption patterns reveal that
the total opioid consumption is frequently lower than
the quantity prescribed. Results from our questionnaire suggest that patients frequently use opioids
even though they feel that their pain is insufficient to
deserve such an intervention (10.5%). Euphoria is also
experienced by a significant number of patients taking
prescription opioids (9.5%). It is also important to note
that some patients recourse to drugs such as marijuana
to relieve pain (3%). Furthermore, patients rarely offer their personal prescription opioids to friends and
family members (0.5%) and often times, patients opt to
not take any opioids, although they had prescriptions
(19%).
Although, in terms of percentages these above
observations are small, it is important to extrapolate
these figures to total national opioid prescriptions and
the public health hazard posed by such conduct. In addition, one should bear in mind that patients may be
hesitant to disclose such aspects of opioid use/misuse,
even in a confidential research setting and as a result
the real magnitude of problem at national level is likely
to be significantly more than revealed in our study.
As mentioned in the results, Table 1 summarizes
the statistics from the binary logistic regression conducted to predict opioid misuse. While the model was
not significant, it is important to note that the race
predictor used in the model did result in a significant
finding, indicating that blacks are more likely to misuse
opioids than whites. Although this cannot be considered a significant finding due the model’s overall insig-
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nificance, its implications could be useful for guiding
future opioid prescription behavior. Furthermore, it is
worthy to note that these findings are in contrast to
those concluded from a study conducted by Unick et al
(11) who found that whites, women, and middle-aged
individuals had the largest increase in prescription
related opioid overdoses since 2007. While our study
did not aim at predicting opioid related overdoses, we
believe that opioid misuse is a major contributor to
opioid overdose.
For all types of surgeries, the average prescription
was higher than the average MME consumed per day.
These results support those findings found by Makary
et al (12) which conclude that over prescription is a
major contributor to the opioid epidemic.
Our study indicates that patients undergoing
orthopedic surgeries often use opioids even though
they feel that pain is insufficient to deserve such an
approach. Similar findings were reported by Shah et
al (13). Their retrospective database study included a
large number of managed care plans and was representative of the U.S. commercially insured population.
They noticed that, in cancer-free adults who received a
prescription for opioid pain relievers, the likelihood of
chronic opioid use increased with each additional day
of medication supplied starting with the third day, with
the sharpest increases in chronic opioid use observed
after the fifth and thirty-first day on therapy. Other factors that contributed to chronic use included a second
prescription or refill, 700 morphine milligram equivalents cumulative dose, and an initial 10- or 30-day
supply. Similarly, Harbaugh et al (14) found persistent
opioid use in 4.8% of children who filled a postoperative opioid prescription.
Research suggests that cannabis should not necessarily be considered an optimal choice as a drug for pain
management (15). However, the general absence of CBD
in what is used “medically,” and the methodological
challenges in conducting research are some of the proposed challenges in making such recommendations (16).
A study found that the prevalence rate for borrowing someone’s prescription medication was 5%
to 51.9% and for lending prescription medication
to someone else was 6% to 22.9%. Sharing primarily
occurs between family members, friends, and acquaintances (17). Both recreational and nonrecreational
sharing is seen. In another study (18), a total of 20.7%
(weighted percentage) reported ever having shared
opioid medications with another person. This is primarily done to help the other person manage pain.

E235

Pain Physician: March/April 2021 24:E231-E237

Euphoria is especially common with fentanyl,
fentanyl analogs, and other new synthetic opioids
(19). Currently, fentanyl is one of the most commonly
abused/misused opioid drugs in the USA (20). In our
study, 19 patients (9.5%) reported in the affirmative on
the question of experiencing euphoria.
Thirty-eight patients (19%) in our study preferred
to take no opioids at all post-surgery, even though they
had prescriptions. This indicates that we fail to recognize the patients who would take/require/benefit from
such a prescription. While it is likely that many patients
may have preferred to tolerate pain for the fear of addiction after appropriate consumption, there could be
other reasons why patients may have preferred not to
take opioids. One of which is opioid induced constipation (OIC). OIC is one of the most common side effects
of opioid consumption and is experienced by more
than 40% of patients taking opioids for chronic noncancer pain (21). As the amount of prescription opioids
increase, it is likely that more patients are dissuaded
from using such opioids out of fear from such gastrointestinal symptoms (22). Along with OIC, urinary retention is also a major factor that may dissuade patients
from consuming prescription opioids (23).

There were also a few limitations to the scope of
our study. Firstly, patients are self-selected and had
the option to opt out of the study when contacted.
Furthermore, some patients may not have been available to answer the phone when our study was being
conducted. This is the reason for our 24.2% turnover
rate when considering the patients screened and those
called (200 out of 826). This resulted in our study not
being entirely random, since particular demographics
may be more likely to answer and opt in to the study.
Secondly, this study was only conducted for orthopedic
patients and for patients who received surgery at the
University of Pennsylvania Presbyterian Hospital, thus
further affecting the demographics for our research.
Future directions include incorporating more patients from other types of surgeries as well as considering a greater number of patients for our predictive
model. Screening patients in person rather than over
the phone may also help provide more accurate data
as well as a greater total number of patents. Perhaps
talking with patients prior to surgery could also help
mitigate possible opioid misuse or over prescription.
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